Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

176.98 +3.04 (+1.75%)
Official Closing Price Updated: 4:10 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug
 
Via Benzinga
What Are Whales Doing With Johnson & Johnson
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Thoughts For Thursday: Ugly and Uglier
Saying Wednesday was not a good day for institutional and Jane and John investors alike is an understatement. At the closing bell, everything was down except for TJ Maxx. 
Via Talk Markets
3 Safe Stocks to Buy As We Head For a Recession
Fears of an economic recession are looming large for myriad reasons. But that doesn't means there aren't some gems in the rough to be found. 
Via Talk Markets
Sector Rotation And 9 Stocks To Watch During A Recession
Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as rising... 
Via Benzinga
IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge
IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured Genomic Data Marketplace and Proprietary GenēUS™ Discovery PlatformWASHINGTON - May 12, 2022 -... 
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
5 Stocks to Buy for the Coming Recession
Each of these stocks to buy are low-beta stocks with attractive dividend yields to help endure a recession. 
Via InvestorPlace
Psychedelics Atai Life Sciences: Optimizing Drug Development By Avoiding Big Pharma's Past Missteps
In the early days of the psychedelics industry, financial reports mean very little. Unless a company wildly misses its operating spending budget and hemorrhages cash by more than expected, the report... 
Via Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
8 Analysts Have This to Say About Johnson & Johnson
Analysts have provided the following ratings for Johnson & Johnson (NYSE:JNJ) within the last quarter: 
Via Benzinga
Point of Care Diagnostics Market Research Insight 2022| Key Players are Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson & Johnson Services, Inc., Hoff
Via iCrowdNewswire
Dollar Gains Traction As Fed Aims To Tame Inflation
Many currencies across the world sank to their weakest levels in years last week as surprisingly robust U.S. inflation data gave fresh impetus to a months-long rally in the dollar. 
Via Talk Markets
Inflation May Have Peaked: What to Do Now
Last week was another loss, but it ended on a sweeter note after Friday’s rally. Now, we're taking a closer look at inflation and the market. 
Via InvestorPlace
Johnson & Johnson Stock: A Rare Bright Spot in the Market
JNJ stock is up on the year thanks in part to its steadily rising dividend, which investors covet during the current market volatility. 
Via InvestorPlace
Wall Street Extends Weekly Losing Streak Despite Upbeat Session
After a tumultuous week, Wall Street's midday rally held strong through the closing bell. 
Via Talk Markets
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
 
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid... 
Via Benzinga
Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock
U.S. marketing application filing for Cidara Therapeutics Inc's (NASDAQ: CDTX) rezafungin remains on track for mid-2022, setting up a potential early 2023 approval and launch. 
Via Benzinga
Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco
 
Via Benzinga
Tuesday Talk: The Rough Ride Continues
At the moment there seems to be no respite on the ride down, markets opened the week on Monday, by closing markedly down again. Market futures are still up heading into the open. 
Via Talk Markets
Let Dividend Stocks Protect You From The Bear Market
The market has been brutal in 2022, especially over the past couple of months. 
Via Talk Markets
This Is What Whales Are Betting On Johnson & Johnson
A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades. 
Via Benzinga
4 Blue-Chip Stocks to Buy for May 2022
Apple, Alphabet, Johnson & Johnson and Procter & Gamble are our blue-chip stocks to buy this month as bulls looks for safe yet solid stocks. 
Via InvestorPlace
9 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, May 6
Reuters IHG Hotels & Resorts On Way To Recovery As Travel Booms 
Via Benzinga
FDA Limits Use of Johnson & Johnson's COVID-19 Vaccine to Certain Individuals - All You Should Know
The FDA said it was limiting the use of Johnson & Johnson's (NYSE: 
Via Benzinga
Johnson & Johnson Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades. 
Via Benzinga
US Study Shows Omicron As Severe As Previous COVID Variants: Reuters
 
Via Benzinga
What ETF Is Best? 7 Great Funds to Consider.
ETF investing is a great way to gain exposure to thematic stocks while limiting downside risk with diversification. 
Via InvestorPlace
3 Mighty Mutual Funds to Buy for Q2
Investors looking to profit from growth across industries should consider these three robust mutual funds to buy. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.